Arthur T Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber s Adult Oncology Program miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June.
VolitionRx (NYSE-A:VNRX) Limited said it has appointed Diagnostic Oncology CRO, LLC (DXOCRO) to undertake development and clinical validation studies for.